Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients

NCT01643811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2016-03-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether the extent of gastrectomy and anastomosis type affect chronic metabolic disease such as diabetes and hypertension in early gastric cancer patients.

Conditions

  • Early Gastric Cancer

Interventions

PROCEDURE

gastrectomy

subtotal gastrectomy with gastroduodenostomy or loop gastrojejunostomy or Roux Y gastrojejunostomy total gastrectomy with Roux Y esophagojejunostomy

PROCEDURE

Endoscopic submucosal dissection

endoscopic submucosal dissection

Sponsors & Collaborators

  • National Cancer Center, Korea

    lead OTHER_GOV

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01643811 on ClinicalTrials.gov